[
1. Aresu L., Aricò A., Comazzi S., Gelain M.E., Riondato F., Mortarino M., Morello E., Stefanello D., Castagnaro M.: VEGF and MMP-9: biomarkers for canine lymphoma. Vet Comp Oncol 2012, 10, 1476-1481.10.1111/j.1476-5829.2012.00328.x22489798
]Search in Google Scholar
[
2. Bałan B.J., Słotwiński R.: VEGF and tumor angiogenesis. Centr Eur J Immunol 2008, 33, 232-236.
]Search in Google Scholar
[
3. Campos A.G., Campos J.A.D.B., Sanches D.S., Dagli M.L.Z., Matera J.M.: Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open J Vet Med 2012, 2, 191-195.10.4236/ojvm.2012.24030
]Search in Google Scholar
[
4. Clifford C.A., Hughes D., Beal M.W., Mackin A.J., Henry C.J., Shofer F.S., Sorenmo K.U.: Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Intern Med 2001, 15, 131-135.10.1111/j.1939-1676.2001.tb01244.x
]Search in Google Scholar
[
5. De Queiroz G.F., Dagli M.L., Fukumasu H., Zavala A.A., Matera J.M.: Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs. J Vet Diagn Invest 2010, 22, 105-108.10.1177/10406387100220012120093695
]Search in Google Scholar
[
6. De Queiroz G.F., Dagli M.L., Meira S.A., Matera J.M.: Serum vascular endothelial growth factor in dogs with soft tissue sarcomas. Vet Comp Oncol 2013, 11, 230-235.10.1111/j.1476-5829.2011.00316.x22372675
]Search in Google Scholar
[
7. Halper J.: Growth Factors as active participants in carcinogenesis: a perspective. Vet Pathol 2010, 47, 77-97.10.1177/030098580935298120080487
]Search in Google Scholar
[
8. Hendrick M.J., Mahaffey E.A., Moore F.M., Vos J.H, Walder E.J.: Histological classification of mesenchymal tumors of skin and soft tissues of domestic animals. Armed Forces Institute of Pathology in cooperation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, 2007, pp. 64.
]Search in Google Scholar
[
9. Hucz J., Szala S.: VEGFR 2 receptor-target for anticancer therapy. Współcz Onkol 2006, 10, 506-514.
]Search in Google Scholar
[
10. Łojko A., Komarnicki M.: Vascular endothelial growth factor in tumor angiogenesis. Współcz Onkol 2004, 8, 1-4.
]Search in Google Scholar
[
11. Sabattini S., Bettini G.: An immunohistochemical analysis of canine haemangioma and haemangiosarcoma. J Comp Pathol 2009, 140, 158-168.10.1016/j.jcpa.2008.10.00619091326
]Search in Google Scholar
[
12. Sapierzyński R., Sapierzyńska E.: Vascular neoplasms in dogs and cats. Życie Wet 2005, 80, 36-40.
]Search in Google Scholar
[
13. Sapierzyński R., Malicka E., Bielecki W., Krawiec M., Osińska B., Sendecka H., Sobczyk-Filipiak M.: Splenomegaly in dogs: a survey of 97 cases. Med Weter 2007, 63, 88-91.
]Search in Google Scholar
[
14. Sapierzyński R.: Tumour of the hematopoietic tissue in dogs and cats. Part I. Canine lymphoma-diagnosis, treatment and prognosis. Życie Wet 2008, 83, 353-360.
]Search in Google Scholar
[
15. Sobczyńska-Rak A., Silmanowicz P., Sobolewska E.: Angiogenesis in malignant spleen cancers in dogs. Med Weter 2009, 65, 693-696.
]Search in Google Scholar
[
16. Sobczyńska-Rak A.: The role of VEGF in process of neovasculogenesis. In: Tumor Angiogenesis. Edited by Ran S., Intech, Rijeka, Croatia, 2012, pp. 181-196.10.5772/30233
]Search in Google Scholar
[
17. Szala S.: Angiogenesis and immune suppression: yin and yang of tumor progression? Postępy Hig Med Dośw 2009, 63, 598-612.
]Search in Google Scholar
[
18. Thielemann A., Kopczyński Z., Baszczuk A., Ćwiklińska K., Grodecka-Gazdecka S.: Assessment of sVEGF-1 concentration in patients with breast cancer. Współcz Onkol 2010, 14, 189-195.10.5114/wo.2010.14128
]Search in Google Scholar
[
19. Uchida N., Nagai K., Sakurada Y., Shirota K.: Distribution of VEGF and flt-1 in the normal dog tissues. J Vet Med Sci 2008, 70, 1273-1276.10.1292/jvms.70.127319057151
]Search in Google Scholar
[
20. Valli V.E.:Histological classification of hematopoietic tumors of domestic animals. Armed Forces Institute of Pathology, in cooperation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, 2002, pp. 190.
]Search in Google Scholar
[
21. Yonemaru K., Sakai H., Murakami M., Yanai T., Masegi T.: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (Flt-1, Flk-1, and Flg-1) in canine vascular tumors. Vet Pathol 2006, 43, 971-980.10.1354/vp.43-6-97117099154
]Search in Google Scholar
[
22. Wąsik-Szczepanek E., Koczkodaj D.: Vascular endothelial growth factor (VEGF) and its role in B-cell chronic lymphocytic leukemia. Acta Haematol Pol 2008, 39, 197-205.
]Search in Google Scholar
[
23. Wergin M.C., Kaser-Hotz B.: Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumors. In Vivo 2004, 18, 15-19.
]Search in Google Scholar
[
24. Wolfesberger B., Tonar Z., Witter K., Guija de Arespocohaga A., Skalicky M., Walter I., Thalhammer G.F.: Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression. Res Vet Sci 2008, 85, 56-61.10.1016/j.rvsc.2007.07.00817888471
]Search in Google Scholar
[
25. Wróbel T.: Angiogenesis in haematologic malignancies. Acta Haematol Pol 2004, 35, 493-504.
]Search in Google Scholar
